患有异常性过活膀的女性患者对肉毒毒素治疗的坚持:48个月的现实世界观察性研究
Sebastian Nestler1, Britta Grüne2, Lydia Schilchegger3
1Urological Practice, Urogate, Bad Vilbel, Germany. sebastian-nestler@web.de.
International urology and nephrology
|April 12, 2025
概括
患有异常性过活性膀 (iOAB) 的女性患者在四年内对肉毒素A疗法表现出良好的坚持. 治疗导致尿失禁发作和膀容量的显著改善,患者满意度高.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 药理学 药理学是指药理学的学科.
- 患者的治疗结果.
背景情况:
- 异常性过活性膀 (iOAB) 显著影响生活质量.
- 毒素A注射是一种耐火性IOAB的治疗选择.
- 在女性患者中,肉毒素A治疗的长期坚持和结果需要进一步评估.
研究的目的:
- 评估接受肉毒毒素A的IOAB女性患者的治疗坚持率.
- 在4年的随访期内评估治疗疗效和患者满意度.
主要方法:
- 对接受静脉注射100AE肉毒素A治疗IOAB的女性患者的前性评估.
- 收集的数据包括治疗效益,急性失禁发作 (UIE),膀容量,重复注射,不良事件和坚持.
- 随访时间为48个月.
主要成果:
- 在91名女性中,70.3% (64名患者) 在48个月后继续治疗.
- 毒素A显著减少UIE每天2.64次,膀容量增加 (中位数为105-207cc).
- 在34.1%的患者中实现了完全的节制,满意度很高 (78.0%在第二个周期后).
结论:
- 患有IOAB的女性患者表现出对肉毒素A疗法的良好坚持.
- 该疗法可持续改善UEE和膀容量.
- 患者高满意度支持肉毒素A在IOAB管理中的长期效用.
相关概念视频
01:17Drugs for Treatment of Diarrhea-Predominant IBS
124
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
124
01:21Drugs for Treatment of Constipation-Predominant IBS
112
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
112